ARTICLE | Finance
Zogenix zeros in
Zogenix refiles for IPO to raise up to $90M to fund Phase III pain drug
September 6, 2010 7:00 AM UTC
Zogenix zeros in
Despite the abysmal performance of this year's biotech IPOs, another company is throwing its hat in the ring. Zogenix Inc. is refiling to raise up to $90 million, after withdrawing an IPO to raise up to $86.3 million in August 2008...